Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Hugo A, Tempelman"'
Autor:
Ninée V. E. J. Buchholtz, Lucas E. Hermans, Chijioke N. Umunnakwe, Marieke M. Nühn, Regina Voss, Emma Need, Neeltje A. Kootstra, Irma Maurer, Dorien C. M. de Jong, Jori Symons, Hugo A. Tempelman, Annemarie M. J. Wensing, Monique Nijhuis
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe main obstacle to achieving an HIV-1 cure is the proviral reservoir. To promote equity in HIV cure strategies, it is crucial to study the viral reservoir of the predominant HIV-1 subtype C in both women and men. Therefore, we investiga
Externí odkaz:
https://doaj.org/article/cb7079436e894078b14b9014db465d08
Autor:
Irtiza S. Tahir, Alinda G. Vos, Johanna A.A. Damen, Roos E. Barth, Hugo A. Tempelman, Diederick E. Grobbee, Karine Scheuermaier, Willem D.F. Venter, Kerstin Klipstein-Grobusch
Publikováno v:
Southern African Journal of HIV Medicine, Vol 23, Iss 1, Pp e1-e10 (2022)
Background: Current cardiovascular risk assessment in people living with HIV is based on general risk assessment tools; however, whether these tools can be applied in sub-Saharan African populations has been questioned. Objectives: The study aimed t
Externí odkaz:
https://doaj.org/article/c5ab32b0ac984f60a48cfafdf8eac941
Autor:
Chijioke N Umunnakwe, Zinhle N Makatini, Mathapelo Maphanga, Anele Mdunyelwa, Khamusi M Mlambo, Puseletso Manyaka, Monique Nijhuis, Annemarie Wensing, Hugo A Tempelman
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0269071 (2022)
The rapid emergence and spread of numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants across the globe underscores the crucial need for continuous SARS-CoV-2 surveillance to ensure that potentially more pathogenic variants
Externí odkaz:
https://doaj.org/article/daf96b25c1e34e7c8e9b57036ba77276
Autor:
Annemiek E. M. de Vries, Zanele Xaba, Sehulong R. Moraba, Luise Goerlitz, Hugo A. Tempelman, Kerstin Klipstein‐Grobusch, Lucas E. Hermans, Karine Scheuermaier, Walter L. J. M. Devillé, Alinda G. Vos
Publikováno v:
Tropical Medicine & International Health. 28:367-373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f042f9caf8715eafe8689389a73df84
https://doi.org/10.1111/tmi.13871
https://doi.org/10.1111/tmi.13871
Autor:
Laura E. P. Huyveneers, Mathapelo Maphanga, Chijioke N. Umunnakwe, Larissa Bosman‐de Boer, Robert S. Moraba, Hugo A. Tempelman, Annemarie M. J. Wensing, Lucas E. Hermans
Publikováno v:
Tropical Medicine & International Health. 28:335-342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::162f6b087915a2ae8b31ccd11fa9d0ce
https://doi.org/10.1111/tmi.13864
https://doi.org/10.1111/tmi.13864
Autor:
Alinda G. Vos, Roos E. Barth, Kerstin Klipstein‐Grobusch, Hugo A. Tempelman, Walter L. J. Devillé, Caitlin Dodd, Roel A. Coutinho, Diederick E. Grobbee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 7 (2020)
Background HIV is associated with an increased risk of cardiovascular disease (CVD) in high‐income countries. Little is known about the CVD burden in sub‐Saharan Africa, where 70% of the world's HIV‐positive population lives. This study aims to
Externí odkaz:
https://doaj.org/article/e1128cae787d4f8ca04059c0e6b9b7ae
Autor:
Lucas E Hermans, Sergio Carmona, Monique Nijhuis, Hugo A Tempelman, Douglas D Richman, Michelle Moorhouse, Diederick E Grobbee, Willem D F Venter, Annemarie M J Wensing
Publikováno v:
PLoS Medicine, Vol 17, Iss 2, p e1003037 (2020)
BACKGROUND:Uptake of antiretroviral treatment (ART) is expanding rapidly in low- and middle-income countries (LMIC). Monitoring of virological suppression is recommended at 6 months of treatment and annually thereafter. In case of confirmed virologic
Externí odkaz:
https://doaj.org/article/0347ed473be24d5a97a6cb20c7b4718e
Autor:
Lucas E Hermans, Chijioke N Umunnakwe, Samanta T Lalla-Edward, Shane K Hebel, Hugo A Tempelman, Monique Nijhuis, Willem D F Venter, Annemarie M J Wensing
Publikováno v:
Clinical Infectious Diseases. 76:e553-e560
Background Viral rebound during antiretroviral treatment (ART) is most often driven by suboptimal adherence in the absence of drug resistance. We assessed the diagnostic performance of point-of-care (POC) tenofovir (TFV) detection in urine for the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58cae597712ebb1d150420f477b8510a
https://doi.org/10.1093/cid/ciac755
https://doi.org/10.1093/cid/ciac755
Autor:
Meri R J Varkila, Alinda G Vos, Roos E Barth, Hugo A Tempelman, Walter L J Devillé, Roel A Coutinho, Diederick E Grobbee, Kerstin Klipstein-Grobusch
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210573 (2019)
ObjectivesHIV infection has been associated with an impaired lung function in high-income countries, but the association between HIV infection and pulmonary function in Sub-Saharan Africa remains unclear. This study aims to investigate the relation b
Externí odkaz:
https://doaj.org/article/c665362e089f4021b2b41c7ae84ad5fc
Autor:
Lucas E, Hermans, Laura M, Hofstra, Rob, Schuurman, Rob, Ter Heine, David M, Burger, Stijn A J, Talboom, Dorien, De Jong, Hugo A, Tempelman, Willem D F, Venter, Monique, Nijhuis, Annemarie M J, Wensing
Publikováno v:
Aids, 36, 923-931
Aids, 36, 7, pp. 923-931
Aids, 36, 7, pp. 923-931
Pretreatment drug resistance (PDR) prevalence in sub-Saharan Africa is rising, but evidence of its impact on efavirenz (EFV)-based antiretroviral treatment (ART) is inconclusive. We determined the impact of PDR on outcomes of EFV-based ART in a suban
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1ca149fcb76701f8f25b4a1a0167d1
https://doi.org/10.1097/qad.0000000000003182
https://doi.org/10.1097/qad.0000000000003182